Evidence map›Paper›PMID 28608231›Full record

ArticleInternational journal of hematology2017

Extradural plasmacytoma with central nervous system involvement in newly diagnosed multiple myeloma.

Satoshi Kaito, Hideharu Muto, Shunta Takebayashi, Yutaka Otsubo, Shuichi Miyawaki, Kazuteru Ohashi

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Multiple myeloma with an unusual presentation.Medical journal, Armed Forces India · 2025
    Article
  2. Multiple myeloma with dural mater involvement.OncoTargets and therapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Satoshi KaitoHematology Division, Tokyo Metropolitan Ohtsuka Hospital, 2-8-1 Minami-Ohtsuka, Toshima-ku, Tokyo, 170-8476, Japan.
Hideharu MutoHematology Division, Tokyo Metropolitan Ohtsuka Hospital, 2-8-1 Minami-Ohtsuka, Toshima-ku, Tokyo, 170-8476, Japan. hydemu2010@gmail.com.ORCID http://orcid.org/0000-0002-9146-012X
Shunta TakebayashiHematology Division, Tokyo Metropolitan Ohtsuka Hospital, 2-8-1 Minami-Ohtsuka, Toshima-ku, Tokyo, 170-8476, Japan.
Yutaka OtsuboNeurosurgery Division, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan.
Shuichi MiyawakiHematology Division, Tokyo Metropolitan Ohtsuka Hospital, 2-8-1 Minami-Ohtsuka, Toshima-ku, Tokyo, 170-8476, Japan.
Kazuteru OhashiHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neoplasms, Multiple PrimaryDiffusion Magnetic Resonance ImagingDura MaterFemaleHumansImmunoglobulin lambda-ChainsMeningeal NeoplasmsMiddle AgedMultiple MyelomaNeoplasm InvasivenessSkull NeoplasmsSyndecan-1Immunoglobulin lambda-ChainsSyndecan-1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.